* If you want to update the article please login/register
Retinopathy has been reported in 19% of the diabetic population of Dubai, with diabetes affecting up to 40% of individuals aged over 55 years. Despite the prevalence of diabetic retinal disorders, there are no national guidelines on diabetic macular edema management. If contraindicated, the Macular laser no longer plays a primary role in center-involving DME, and anti-vascular endothelial growth factor therapy should be considered as first-line therapy for all patients. In addition, recommendations for the care of DME in special circumstances, relapsing, and refractory DME are also discussed.
Source link: https://doi.org/10.1007/s40123-022-00547-2
Purpose About the retinal region of the diabetic macular region, there is a mild case of diabetic macular edema. The article discusses transfer learning's capability to find cases of DME from retinal fundus photographs in order to highlight this. Methods used to extract the useful set of feature vectors from the fundus images, which are then fed into a few additional completely connected layers and then onto the classification layer to classify DME instances. A total of 577 fundus training photos from 3 DME classes was used to develop the new model, and 103 fundus testing photos were used to verify the new model's classification into one of the three DME cases.
Source link: https://doi.org/10.1007/s42600-022-00233-z
Using optical coherence tomography angiography, we can examine the changes in foveal avascular zone area, perimeter, and circularity in the superficial and deep capillary plexuses in eyes with diabetic macular edema treated with intravitreal anti-VEGF. Methods This prospective observational study included 56 eyes from 32 patients with DME who had intravitreal anti-VEGF (intravitreal anti-VEGF). Results The mean number of intravitreal anti-VEGF injections received during the observation period was 4. 60 u00b1 0. 82, according to the study's results. Conclusions The FAZ area, perimeter, and circularity of the SCP and DCP as measured by OCTA remained stable during the first six months of intravitreal anti-VEGF therapy in eyes with DME. Although there were no significant changes in the FAZ, intravitreal anti-VEGF therapy resulted in reduced CST and better BCVA, which was also improved BCVA.
Source link: https://doi.org/10.1186/s40942-022-00406-z
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions